UniProtKB/SwissProt variant VAR

Variant information

Variant position:

477

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

US

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Valine (V) at position 477 (A477V, p.Ala477Val).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and hydrophobic (V)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

0

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In NPHS17; unknown pathological significance.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs1568094661 [ dbSNP | Ensembl ]

Sequence information

Variant position:

477

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

656

The length of the canonical sequence.

Location on the sequence:

CEQRQMTEQVRSICKILAMK A VRNNRLGSALSWSIRAKDAA

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CEQRQMTEQVR-SICKILAMKAVRNNRLGSALSWSIRAKDAA

Mouse                         CEQRQMTEQVK-SICKILAMKAVRNNRLGSALSWSIRAKDA

Rat                           CEQRQMTEQVG-SICKILAMKAVRNNRLGSALSWSIRAKDA

Bovine                        CEQRQMTEQVR-SICKVLAMKAVRNNRLGSALSWSIRAKDA

Xenopus laevis                CEQRQMTEQVR-SICKTMAMQSLCNRRLGSALSWSIRAKDA

Xenopus tropicalis            CEKRQMTEQVR-SICKTMAMQSLCNGRLGSALSWSIRAKDA

Zebrafish                     CEDRQMSEQVR-SICKIMAKRALRNNRLGSALSWSIRAKDA

Slime mold                    -DKWATSVETKNSIYKMLSLQDFKRKRYAASLNWLMLANDN

Baker's yeast                 CVEWRLPEIAK-EIYTTLGNQMLSAHNIIESIANFSRAGKY

Fission yeast                 CKQLKLRDEAQ-LVLTHWADELIARNHYGEALIALDNAANY

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 656	Nuclear pore complex protein Nup85

Literature citations

Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
Braun D.A.; Lovric S.; Schapiro D.; Schneider R.; Marquez J.; Asif M.; Hussain M.S.; Daga A.; Widmeier E.; Rao J.; Ashraf S.; Tan W.; Lusk C.P.; Kolb A.; Jobst-Schwan T.; Schmidt J.M.; Hoogstraten C.A.; Eddy K.; Kitzler T.M.; Shril S.; Moawia A.; Schrage K.; Khayyat A.I.A.; Lawson J.A.; Gee H.Y.; Warejko J.K.; Hermle T.; Majmundar A.J.; Hugo H.; Budde B.; Motameny S.; Altmueller J.; Noegel A.A.; Fathy H.M.; Gale D.P.; Waseem S.S.; Khan A.; Kerecuk L.; Hashmi S.; Mohebbi N.; Ettenger R.; Serdaroglu E.; Alhasan K.A.; Hashem M.; Goncalves S.; Ariceta G.; Ubetagoyena M.; Antonin W.; Baig S.M.; Alkuraya F.S.; Shen Q.; Xu H.; Antignac C.; Lifton R.P.; Mane S.; Nuernberg P.; Khokha M.K.; Hildebrandt F.;
J. Clin. Invest. 128:4313-4328(2018)
Cited for: FUNCTION; INTERACTION WITH NUP160; INVOLVEMENT IN NPHS17; VARIANTS NPHS17 VAL-477; PRO-581 AND TRP-645; CHARACTERIZATION OF VARIANTS NPHS17 VAL-477; PRO-581 AND TRP-645;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BW27: Variant p.Ala477Val